Sanofi SNY NASDAQ

Sanofi (SNY) reported total assets of $126.81B and total liabilities of $55.1B for fiscal year 2025, resulting in total equity of $71.71B.

The company held $7.66B in cash and short-term investments. Total debt stood at $21.79B, with net debt of $14.13B. The Debt-to-Equity (D/E) ratio was 0.3 (conservative).

Current ratio is 1.09, suggesting adequate short-term liquidity. Interest coverage is 11.7x (strong).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.3, current ratio of 1.09, interest coverage 11.7x — balance sheet is strong
• MOAT (90/100) — Total assets $126.81B and equity $71.71B support the company's competitive scale
• VALUE (79/100) — Debt-to-Equity 0.3 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 75/100 with 5/7 criteria passed.

JNJ

Johnson & Johnson

$240.10

+0.90%

ABBV

AbbVie Inc.

$210.32

+1.86%

RHHBY

Roche Holding AG

$51.02

+0.65%

AZN

AstraZeneca PLC

$204.38

+1.06%

MRK

Merck & Co., Inc.

$119.96

-0.16%

NVS

Novartis AG

$153.38

-0.71%

AMGN

Amgen Inc.

$350.95

+0.32%

GILD

Gilead Sciences, Inc.

$140.45

+1.02%